108 related articles for article (PubMed ID: 27959268)
1. Endogenous erythropoietin and erythropoietin receptors in colorectal cancer; can we answer the questions?
Čubranić A; Dobrila-Dintinjana R; Redžović A; Dintinjana M; Petranović D; Golčić M
Med Hypotheses; 2016 Nov; 96():16-19. PubMed ID: 27959268
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts.
Tankiewicz-Kwedlo A; Hermanowicz J; Surażynski A; Rożkiewicz D; Pryczynicz A; Domaniewski T; Pawlak K; Kemona A; Pawlak D
Mol Cell Biochem; 2016 Oct; 421(1-2):1-18. PubMed ID: 27543111
[TBL] [Abstract][Full Text] [Related]
3. The role of erythropoietin and erythropoietin receptor in malignant laryngeal tumors.
Vukelic J; Dobrila-Dintinjana R; Jonjic N; Dekanic A; Ilijic V
Med Hypotheses; 2013 Dec; 81(6):1155-8. PubMed ID: 24134826
[TBL] [Abstract][Full Text] [Related]
4. Mystery Story about Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) are Disguised?
Cubranić A; Redzovic A; Dobrila-Dintinjana R; Vukelić J; Dintinjana M
Hepatogastroenterology; 2015 May; 62(139):585-9. PubMed ID: 26897933
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of erythropoietin and erythropoietin receptor in gastric adenocarcinoma.
Wang L; Li HG; Xia ZS; Wen JM; Lv J
World J Gastroenterol; 2011 Sep; 17(34):3933-40. PubMed ID: 22025882
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
[TBL] [Abstract][Full Text] [Related]
7. Targeted near-infrared imaging of the erythropoietin receptor in human lung cancer xenografts.
Doleschel D; Mundigl O; Wessner A; Gremse F; Bachmann J; Rodriguez A; Klingmüller U; Jarsch M; Kiessling F; Lederle W
J Nucl Med; 2012 Feb; 53(2):304-11. PubMed ID: 22228796
[TBL] [Abstract][Full Text] [Related]
8. Relationships of P53 and Bak with EPO and EPOR in human colorectal cancer.
Baltaziak M; Koda M; Wincewicz A; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Anticancer Res; 2009 Oct; 29(10):4151-6. PubMed ID: 19846965
[TBL] [Abstract][Full Text] [Related]
9. The relationships between hypoxia-dependent markers: HIF-1alpha, EPO and EPOR in colorectal cancer.
Baltaziak M; Wincewicz A; Kanczuga-Koda L; Lotowska JM; Koda M; Sulkowska U; Baltaziak M; Podbielski M; Sobaniec-Lotowska ME; Sulkowski S
Folia Histochem Cytobiol; 2013; 51(4):320-5. PubMed ID: 24497137
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin/erythropoietin receptor system is involved in angiogenesis in human neuroblastoma.
Ribatti D; Poliani PL; Longo V; Mangieri D; Nico B; Vacca A
Histopathology; 2007 Apr; 50(5):636-41. PubMed ID: 17394500
[TBL] [Abstract][Full Text] [Related]
11. Emergence of the erythropoietin/erythropoietin receptor system as a novel cardiovascular therapeutic target.
Satoh K; Fukumoto Y; Nakano M; Kagaya Y; Shimokawa H
J Cardiovasc Pharmacol; 2011 Dec; 58(6):570-4. PubMed ID: 21934628
[TBL] [Abstract][Full Text] [Related]
12. Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients.
Lamanuzzi A; Saltarella I; Ferrucci A; Ria R; Ruggieri S; Racanelli V; Rao L; Annese T; Nico B; Vacca A; Ribatti D
Oncotarget; 2016 Mar; 7(12):14510-21. PubMed ID: 26919105
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin/erythropoietin-receptor system is involved in angiogenesis in human hepatocellular carcinoma.
Ribatti D; Marzullo A; Gentile A; Longo V; Nico B; Vacca A; Dammacco F
Histopathology; 2007 Apr; 50(5):591-6. PubMed ID: 17394495
[TBL] [Abstract][Full Text] [Related]
14. Expression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesis.
Gombos Z; Danihel L; Repiska V; Acs G; Furth E
Indian J Pathol Microbiol; 2011; 54(2):273-8. PubMed ID: 21623073
[TBL] [Abstract][Full Text] [Related]
15. The tumor promoting roles of erythropoietin/erythropoietin receptor signaling pathway in gastric cancer.
Hu W; Zhang Y; Jiang Z; Wang L; Li J; Chen S; Dai N; Si J
Tumour Biol; 2016 Aug; 37(8):11523-33. PubMed ID: 27086036
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of erythropoietin expression in human endometrial carcinoma.
Acs G; Xu X; Chu C; Acs P; Verma A
Cancer; 2004 Jun; 100(11):2376-86. PubMed ID: 15160341
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin blockade inhibits the induction of tumor angiogenesis and progression.
Hardee ME; Cao Y; Fu P; Jiang X; Zhao Y; Rabbani ZN; Vujaskovic Z; Dewhirst MW; Arcasoy MO
PLoS One; 2007 Jun; 2(6):e549. PubMed ID: 17579721
[TBL] [Abstract][Full Text] [Related]
19. The role of erythropoietin in regulating angiogenesis.
Kertesz N; Wu J; Chen TH; Sucov HM; Wu H
Dev Biol; 2004 Dec; 276(1):101-10. PubMed ID: 15531367
[TBL] [Abstract][Full Text] [Related]
20. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
